Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1972 1
1975 1
1978 3
1981 2
1982 1
1983 1
1984 2
1985 3
1986 5
1987 1
1988 8
1989 6
1990 8
1991 5
1992 6
1993 6
1994 15
1995 14
1996 15
1997 16
1998 15
1999 15
2000 18
2001 19
2002 16
2003 23
2004 27
2005 38
2006 38
2007 34
2008 30
2009 43
2010 46
2011 57
2012 73
2013 76
2014 82
2015 85
2016 68
2017 56
2018 101
2019 92
2020 93
2021 95
2022 115
2023 103
2024 123
2025 128

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,664 results

Results by year

Filters applied: . Clear all
Page 1
The new normal.
Papageorghiou AT. Papageorghiou AT. BJOG. 2020 Jun;127(7):779-780. doi: 10.1111/1471-0528.16258. BJOG. 2020. PMID: 32410401 Free PMC article.
[Image: see text] Deputy Editor-in-Chief, Prof Aris T Papageorghiou, discusses the latest thinking in women's health and highlights articles from this issue in an audio podcast available at: https://soundcloud.com/bjog/june-editorial-2020...
[Image: see text] Deputy Editor-in-Chief, Prof Aris T Papageorghiou, discusses the latest thinking in women's health and highl …
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bucher HC, Bhatnagar N, Annane D, Reinhart K, Branche A, Damas P, Nijsten M, de Lange DW, Deliberato RO, Lima SS, Maravić-Stojković V, Verduri A, Cao B, Shehabi Y, Beishuizen A, Jensen JS, Corti C, Van Oers JA, Falsey AR, de Jong E, Oliveira CF, Beghe B, Briel M, Mueller B. Schuetz P, et al. Cochrane Database Syst Rev. 2017 Oct 12;10(10):CD007498. doi: 10.1002/14651858.CD007498.pub3. Cochrane Database Syst Rev. 2017. PMID: 29025194 Free PMC article.
BACKGROUND: Acute respiratory infections (ARIs) comprise of a large and heterogeneous group of infections including bacterial, viral, and other aetiologies. ...Results were similar for different clinical settings and types of ARIs, thus supporting the use of procalc …
BACKGROUND: Acute respiratory infections (ARIs) comprise of a large and heterogeneous group of infections including bacterial, viral, …
5α-Reductase Inhibitors.
Salisbury BH, Leslie SW, Tadi P. Salisbury BH, et al. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32310390 Free Books & Documents.
5alpha-reductase inhibitors (5-ARIs), including finasteride and dutasteride, are approved by the U.S. Food and Drug Administration for treating benign prostatic hyperplasia and androgenic alopecia. ...This educational activity discusses the indications, mechanism of …
5alpha-reductase inhibitors (5-ARIs), including finasteride and dutasteride, are approved by the U.S. Food and Drug Administra …
Exploring the Enigma of 5-ARIs Resistance in Benign Prostatic Hyperplasia: Paving the Path for Personalized Medicine.
Lin Z, Liu Z, Niu Y. Lin Z, et al. Curr Urol Rep. 2023 Dec;24(12):579-589. doi: 10.1007/s11934-023-01188-z. Epub 2023 Nov 21. Curr Urol Rep. 2023. PMID: 37987980 Review.
PURPOSE OF REVIEW: Despite the widespread utilization of 5-alpha reductase inhibitors (5-ARIs) for managing benign prostatic hyperplasia (BPH), certain BPH patients exhibit unresponsiveness to 5-ARIs therapy. This paper provides a comprehensive overview of the curre …
PURPOSE OF REVIEW: Despite the widespread utilization of 5-alpha reductase inhibitors (5-ARIs) for managing benign prostatic hyperpla …
GSTM2 is a key molecular determinant of resistance to SG-ARIs.
Li C, Liu J, He D, Mao F, Rao X, Zhao Y, Lanman NA, Kazemian M, Farah E, Liu J, Ngule CM, Zhang Z, Zhang Y, Kong Y, Li L, Wang C, Liu X. Li C, et al. Oncogene. 2022 Sep;41(40):4498-4511. doi: 10.1038/s41388-022-02444-1. Epub 2022 Aug 29. Oncogene. 2022. PMID: 36038661 Free PMC article.
Unavoidably, emergence of resistance to these novel drugs still persists. Herein, we identified glutathione S-transferase Mu 2 (GSTM2) as an important determinant in the acquisition of resistance to SG-ARIs. ...Taking together, these results provide new insight to a …
Unavoidably, emergence of resistance to these novel drugs still persists. Herein, we identified glutathione S-transferase Mu 2 (GSTM2 …
Indonesia: country report on children's environmental health.
Haryanto B. Haryanto B. Rev Environ Health. 2020 Mar 26;35(1):41-48. doi: 10.1515/reveh-2019-0088. Rev Environ Health. 2020. PMID: 32134738 Review.
Children's bodies are in dynamic stages of development that make them more susceptible to harm from exposure to environmental agents. Children's physical, physiological and behavioral traits can lead to increased exposure to toxic chemicals or pathogens. ...
Children's bodies are in dynamic stages of development that make them more susceptible to harm from exposure to environmental agents. …
Taming Taylor-Aris dispersion through chaotic advection.
Biagioni V, Venditti C, Adrover A, Giona M, Cerbelli S. Biagioni V, et al. J Chromatogr A. 2022 Jun 21;1673:463110. doi: 10.1016/j.chroma.2022.463110. Epub 2022 May 3. J Chromatogr A. 2022. PMID: 35537353
Taylor-Aris dispersion represents an undesired phenomenon in pressure-driven liquid chromatography, often responsible for the unchecked increase of the Height Equivalent of the Theoretical Plate (HETP) when high throughput operating conditions are sought. ...Accurate Lagra …
Taylor-Aris dispersion represents an undesired phenomenon in pressure-driven liquid chromatography, often responsible for the uncheck …
Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide.
Garcia-Argibay M, Hiyoshi A, Fall K, Montgomery S. Garcia-Argibay M, et al. JAMA Netw Open. 2022 Dec 1;5(12):e2248135. doi: 10.1001/jamanetworkopen.2022.48135. JAMA Netw Open. 2022. PMID: 36547981 Free PMC article.
IMPORTANCE: In recent decades, there has been increased interest in the possible adverse neurological effects of 5alpha-reductase inhibitors (5-ARIs), which have been used mainly for benign prostatic hyperplasia and androgenic alopecia. Numerous studies and reports have in …
IMPORTANCE: In recent decades, there has been increased interest in the possible adverse neurological effects of 5alpha-reductase inhibitors …
5-α Reductase Inhibitors and Prostate Cancer Mortality.
Hamilton RJ, Chavarriaga J, Khurram N, Lau C, Luo J, Liu N, Komisarenko M, Kulkarni G, Wallis C, Juurlink DN, Fleshner N, Finelli A. Hamilton RJ, et al. JAMA Netw Open. 2024 Aug 1;7(8):e2430223. doi: 10.1001/jamanetworkopen.2024.30223. JAMA Netw Open. 2024. PMID: 39190306 Free PMC article.
However, trials also have shown 5-ARIs to be associated with high-grade PCa. Whether 5-ARIs increase mortality among those with a diagnosis of PCa remains unclear. ...This study offers reassuring safety data for patients using 5-ARIs before PCa diagnosis for …
However, trials also have shown 5-ARIs to be associated with high-grade PCa. Whether 5-ARIs increase mortality among those wit …
PNEUMOCOCCAL SEROTYPE DISTRIBUTION AND COVERAGE OF EXISTING AND PIPELINE PNEUMOCOCCAL VACCINES.
King LM, Andrejko KL, Kobayashi M, Xing W, Cohen AL, Self WH, Resser JJ, Whitney CG, Baughman A, Kio M, Grijalva CG, Traenkner J, Rouphael N, Lewnard JA. King LM, et al. medRxiv [Preprint]. 2024 Dec 13:2024.12.12.24318944. doi: 10.1101/2024.12.12.24318944. medRxiv. 2024. Update in: J Infect Dis. 2025 Oct 15;232(4):e609-e620. doi: 10.1093/infdis/jiaf376. PMID: 39711720 Free PMC article. Updated. Preprint.
We aimed to estimate 1) proportions of IPD cases and pneumococcal ARIs caused by serotypes targeted by existing and pipeline PCVs and 2) annual U.S. pneumococcal burdens potentially preventable by PCVs. METHODS: We estimated serotype distribution and proportions of …
We aimed to estimate 1) proportions of IPD cases and pneumococcal ARIs caused by serotypes targeted by existing and pipeline PCVs and …
1,664 results